ibd and glp 1 🚨 GLP-1 RA use in is rising fast In this 14-month repeated survey of patients with IBD: 📈 GLP-1 RA use rose 5-fold ⚖️ Median BMI fell from 35.3 → 31.2 Recommendations for the safe and

Headaches: Some users may experience headaches after using the nasal spray

2-

As more people discover their advantages, GLP-1s are being prescribed earlier in the treatment journey, often displacing longstanding first-line therapies like metformin

Learn More Submit Now Click through the PLOS taxonomy to find articles in your field

Enhancing the scoping study methodology: a large, inter-professional teams experience with Arksey and OMalleys framework

After writing dozens of GLP-1 articles over the past year, one issue that consistently comes up is the affordability of popular medications like Ozempic, Wegovy and Zepbound for weight loss